Suction blister device for separation of viable epidermis from dermis.
about
Importance of relating efficacy measures to unbound drug concentrations for anti-infective agentsIloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patientsEnhanced neutrophil migration in vivo HLA B27 positive subjects.Matrix-metalloproteinase-2, -8 and -9 in serum and skin blister fluid in patients with severe sepsis.92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen.The stereoselective disposition of the enantiomers of ibuprofen in blood, blister and synovial fluidThe distribution of cis- and trans-acitretin in human epidermisIncreased prostaglandins E2 and F2alpha in human skin at 6 and 24 h after ultraviolet B irradiation (290- 320 nm).Use of human mucosal tissue to study HIV-1 pathogenesis and evaluate HIV-1 prevention modalities.Tissue penetration by ertapenem, a parenteral carbapenem administered once daily, in suction-induced skin blister fluid in healthy young volunteers.Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteersIdentification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigenBiodistribution of etanercept to tissues and sites of inflammation in arthritic rats.Altered epitope expression of human interstitial fluid apolipoprotein A-I reduces its ability to activate lecithin cholesterol acyl transferaseHuman suction blister interstitial fluid prevents metal ion-dependent oxidation of low density lipoprotein by macrophages and in cell-free systems.Higher vascular endothelial growth factor-C concentration in plasma is associated with increased forearm capillary filtration capacity in breast cancer-related lymphedema.Levels of atherogenic lipoproteins are unexpectedly reduced in interstitial fluid from type 2 diabetes patients.Extracellular matrix proteins of human epidermal keratinocytes and feeder 3T3 cellsAn integrative metabolomics and transcriptomics study to identify metabolic alterations in aged skin of humans in vivoDemonstration of increased collagen synthesis in irradiated human skin in vivo.Detection of active kallikrein in induced blister fluids of hereditary angioedema patients.Topical treatment with coenzyme Q10-containing formulas improves skin's Q10 level and provides antioxidative effects.Epidermal wound healing in severe sepsis and septic shock in humans.Lymphatic transport of high-density lipoproteins and chylomicrons.Technologies for continuous glucose monitoring: current problems and future promises.Cefodizime in serum and skin blister fluid after single intravenous and intramuscular doses in healthy volunteers.Interface-area-to-volume ratio of interstitial fluid in humans determined by pharmacokinetic analysis of netilmicin in small and large skin blisters.Cell communication in the basal cells of the human epidermisThe use of skin biopsy in the diagnosis of the glycogen-storage diseases.Accessible standardized intracutaneous implants: pancreatic adenocarcinoma in the Syrian hamster.Modified skin-window technique in cynomolgus macaques (Macaca fasicularis) for assessing neutrophil extravasation.Mathematical model to predict skin concentration after topical application of drugs.Modified skin window technique for the extended characterisation of acute inflammation in humans.Elevated expression and release of tissue-type, but not urokinase-type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes.Human Suction Blister Fluid Composition Determined Using High-Resolution Metabolomics.Extraction and biomolecular analysis of dermal interstitial fluid collected with hollow microneedlesProlonging culture of primary human keratinocytes isolated from suction blisters with the Rho kinase inhibitor Y-27632A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo
P2860
Q26827380-88BAC64C-80E4-40C5-9B66-33D539335154Q28344134-3ABC5A6E-59B0-4E89-ABAB-9716F2256A91Q33555249-BA4516D3-634D-4E11-B64D-1271A0BC81F2Q33919160-97F63577-AA73-483C-B7E9-23D279F99C58Q34143851-65B4C976-2B8B-4BB2-850F-6138318F237BQ34346269-71C15C2E-2A56-4AE5-8D47-13D95F882DDFQ34402902-0EFC3AF5-E50A-4CDF-A68A-7E7E436C3A84Q34516526-DCC6DC74-2D0C-4F1E-A4DD-39CC6C7F85BFQ34566597-02017023-D9FF-4C59-BB6A-BD07BEF3B697Q34883132-1A73DEAD-3452-408E-9523-909A8705B193Q35245897-80F657CB-6727-4204-A8D0-F54DA25443B9Q35586376-95A4681F-69DE-43AA-AE32-818711910BDFQ35600264-483948DC-222F-4304-995D-746441CCE917Q35613437-E639A1AC-045A-41D0-9353-DA697D9BF454Q35764845-06A1CB43-FE61-4E9A-8EAF-BED401341E37Q35877534-337E9662-BE73-4C5C-99BE-27A5C7EF48D7Q35886333-BEE4AADF-FD4C-4620-B428-56858E556280Q36206501-E81687B6-6E29-4F1B-804C-D4E6419C7496Q36281591-43EAB7F7-6CE3-4DCD-A19A-7C5C866FCCC7Q36292970-1CD5969B-F963-4FA4-B622-01EBDD0BD178Q36343887-A33D0850-339A-41D4-933B-966EFB2A9037Q36533032-CF5CA198-87DB-4951-8265-2073F497EAF3Q37279926-086293CF-518D-4354-BB5F-A1D64EDB6A65Q37602219-3D2E17FB-1C77-4580-9BAB-106F91AD2DB4Q37815571-7D4A1B3F-6534-4086-8C53-312769B4C22CQ39829105-94463D97-41F3-4A22-86B3-EDBB40C4EEBFQ40086488-CC2B9812-2002-451F-B250-17398F3F0A1CQ41633275-01042AE5-4FBB-4ADB-B2F3-7E1F8BE20260Q41833227-6000E316-1F25-4E92-A205-A8A95FD2E3FEQ42042500-91EA588E-7EEE-4465-BEC0-7A4CF7970C4BQ42237612-37237C9D-4B0C-4F15-90C9-06ED22384161Q42774257-AA6ED3BF-C50C-4621-AC51-867259A5B785Q43193110-8694E6B3-1CDF-4F9B-B955-7D2159EC4CFFQ47981566-E5C70895-869F-444C-8853-81B9CD5D77A5Q50100305-E857CEAA-CFF7-4EBE-B304-5ED7D808498DQ58120220-BC2477B1-6C3D-4F5A-92F4-F03961825F3EQ58748112-54539CFB-3127-41B6-8A31-6A78AA708C56Q58788228-F62C69E2-AD66-426E-B5D0-5C685C6A0D7A
P2860
Suction blister device for separation of viable epidermis from dermis.
description
1968 nî lūn-bûn
@nan
1968年の論文
@ja
1968年学术文章
@wuu
1968年学术文章
@zh
1968年学术文章
@zh-cn
1968年学术文章
@zh-hans
1968年学术文章
@zh-my
1968年学术文章
@zh-sg
1968年學術文章
@yue
1968年學術文章
@zh-hant
name
Suction blister device for separation of viable epidermis from dermis.
@en
type
label
Suction blister device for separation of viable epidermis from dermis.
@en
prefLabel
Suction blister device for separation of viable epidermis from dermis.
@en
P1476
Suction blister device for separation of viable epidermis from dermis.
@en
P2093
Kiistala U
P304
P407
P577
1968-02-01T00:00:00Z